FHIR Implementation Guide for NJSAMS
1.0.0 - release
1.0.0 - release
NJSAMS - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/InhalentUseDisordersQuestionnaire | Version: 1.0.0 | |||
| Draft as of 2022-08-31 | Computable Name: | |||
Criteria for Inhalent Use Disorder
Generated Narrative: Questionnaire InhalentUseDisordersQuestionnaire
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  | Criteria for Inhalent Use Disorder | Questionnaire | https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/InhalentUseDisordersQuestionnaire#1.0.0 | |
  InhalDisSymptoms | null | 0..1 | group | |
  InhalDisSymptoms.401 | 401. The inhalant substance is often taken in larger amounts or over a longer period than was intended. | 0..1 | boolean | |
| InhalDisSymptoms.402 | 402. A great deal of time is spent in activities necessary to obtain the inhalant substance, use it, or recover from its effects. | 0..1 | boolean | |
| InhalDisSymptoms.403 | 403. There is a persistent desire or unsuccessful efforts to cut down or control use of the inhalant substance. | 0..1 | boolean | |
| InhalDisSymptoms.404 | 404. Craving, or a strong desire or urge to use the inhalant substance. | 0..1 | boolean | |
| InhalDisSymptoms.405 | 405. Recurrent use of the inhalant substance resulting in a failure to fulfill major role obligations at work, school, or home. | 0..1 | boolean | |
| InhalDisSymptoms.406 | 406. Continued use of the inhalant substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use. | 0..1 | boolean | |
| InhalDisSymptoms.407 | 407. Important social, occupational, or recreational activities are given up or reduced because of use of the inhalant substance. | 0..1 | boolean | |
| InhalDisSymptoms.408 | 408. Recurrent use of the inhalant substance in situations in which it is physically hazardous. | 0..1 | boolean | |
| InhalDisSymptoms.409 | 409. Use of the inhalant substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. | 0..1 | boolean | |
 InhalDisSymptoms.410 | 410. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the inhalant substance to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the inhalant substance. | 0..1 | boolean | |
| InhalIntoxSymptoms | null | 0..1 | group | |
| InhalIntoxSymptoms.425 | 425. A. Recent intended or unintended short-term, high dose exposure to inhalant substances, including volatile hydrocarbons such as toluene or gasoline. | 0..1 | boolean | |
| InhalIntoxSymptoms.426 | 426. B. Clinically sig. problematic behavioral or psychological changes that developed during or shortly after exposure to inhalants. | 0..1 | boolean | |
| SignsOrSymptoms | C. Two or more of the following signs or symptoms developing during or shortly after inhalant use or exposure: | 0..1 | group | |
 InhalIntoxSymptoms.SignsOrSymptoms.428 | 428. Dizziness | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.429 | 429. Nystagmus | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.430 | 430. Incoordination | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.431 | 431. Slurred Speech | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.432 | 432. Unsteady gait | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.433 | 433. Lethargy | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.434 | 434. Depressed reflexes | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.435 | 435. Psychomotor retardation | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.436 | 436. Tremor | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.437 | 437. Generalized muscle weakness | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.438 | 438. Blurred vision or diplopia | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.439 | 439. Stupor or coma | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.440 | 440. Euphoria | 0..1 | boolean | |
| InhalIntoxSymptoms.SignsOrSymptoms.441 | 441. D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance. | 0..1 | boolean | |
| InhalUnspecifiedSymptoms | null | 0..1 | group | |
| InhalUnspecifiedSymptoms.445 | 445. This category applies to presentations in which symptoms characteristic of an inhalant-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific inhalant-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. | 0..1 | boolean | |
| meetsInhalIntoxCriteria | null | 0..1 | group | |
| meetsInhalIntoxCriteria.1 | Meets Criteria for Inhalant Intoxication Diagnosis? | 0..1 | boolean | |
| Documentation for this format | ||||